These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5720800)

  • 21. Large-scale production of indefinitely propagated cell lines.
    Cooper PD
    Natl Cancer Inst Monogr; 1968 Dec; 29():63-7. PubMed ID: 5720812
    [No Abstract]   [Full Text] [Related]  

  • 22. Characteristics of cell culture systems: viral flora of tissue sources and tissue and medium antigens in vaccines--summary.
    Sigel MM; von Magnus H
    Natl Cancer Inst Monogr; 1968 Dec; 29():551-4. PubMed ID: 4976867
    [No Abstract]   [Full Text] [Related]  

  • 23. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
    Vasington PJ
    Natl Cancer Inst Monogr; 1968 Dec; 29():205-6. PubMed ID: 4976358
    [No Abstract]   [Full Text] [Related]  

  • 24. Virus, chemicals and cancer.
    Casto BC; DiPaolo JA
    Prog Med Virol; 1973; 16():1-47. PubMed ID: 4591689
    [No Abstract]   [Full Text] [Related]  

  • 25. Neoplastic properties of animal cell lines--summary.
    Furth J
    Natl Cancer Inst Monogr; 1968 Dec; 29():559-60. PubMed ID: 5713330
    [No Abstract]   [Full Text] [Related]  

  • 26. Karyologic characteristics of the WI-38 diploid cell system--general comments.
    Rubin BA; Minecci LC; Tint H
    Natl Cancer Inst Monogr; 1968 Dec; 29():97-104. PubMed ID: 5720816
    [No Abstract]   [Full Text] [Related]  

  • 27. Industrial production of primary tissue culture.
    Warren J
    Natl Cancer Inst Monogr; 1968 Dec; 29():35-43. PubMed ID: 4976363
    [No Abstract]   [Full Text] [Related]  

  • 28. The need for a standardised cell substrate for virus vaccine production.
    Perkins FT
    Ann Ist Super Sanita; 1969; 5(1):82-9. PubMed ID: 5382315
    [No Abstract]   [Full Text] [Related]  

  • 29. Vaccines produced in diploid cell lines--discussion.
    Perkins FT
    Natl Cancer Inst Monogr; 1968 Dec; 29():495-7. PubMed ID: 5720803
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification standards of primary cultures and diploid cell lines--discussion.
    Stulberg CS
    Natl Cancer Inst Monogr; 1968 Dec; 29():15-9. PubMed ID: 5720789
    [No Abstract]   [Full Text] [Related]  

  • 31. Continuously propagated cell lines. Biochemical identification standards--discussion.
    Peterson WD
    Natl Cancer Inst Monogr; 1968 Dec; 29():55-7. PubMed ID: 5720808
    [No Abstract]   [Full Text] [Related]  

  • 32. Continuously propagated cell lines. Identification standards: serology.
    Brand KG
    Natl Cancer Inst Monogr; 1968 Dec; 29():51-3. PubMed ID: 5720805
    [No Abstract]   [Full Text] [Related]  

  • 33. Cell cultures for virus vaccine production. General conclusions from the conference.
    Merchant DJ
    Natl Cancer Inst Monogr; 1968 Dec; 29():583-4. PubMed ID: 5720811
    [No Abstract]   [Full Text] [Related]  

  • 34. Technology of production of primary and diploid cell cultures.
    Brackett RG
    Natl Cancer Inst Monogr; 1968 Dec; 29():33-4. PubMed ID: 5720801
    [No Abstract]   [Full Text] [Related]  

  • 35. Tumour cell migration.
    Cochran AJ
    Rev Eur Etud Clin Biol; 1971; 16(1):44-7. PubMed ID: 5555069
    [No Abstract]   [Full Text] [Related]  

  • 36. Viral flora of primate tissues--discussion.
    Malherbe H
    Natl Cancer Inst Monogr; 1968 Dec; 29():177-8. PubMed ID: 5720790
    [No Abstract]   [Full Text] [Related]  

  • 37. Mycoplasma and cell cultures.
    Barile MF
    Natl Cancer Inst Monogr; 1968 Dec; 29():201-4. PubMed ID: 4976863
    [No Abstract]   [Full Text] [Related]  

  • 38. Detection of persistent infections using biophysical methods.
    Anderson NG
    Natl Cancer Inst Monogr; 1968 Dec; 29():393-403. PubMed ID: 4976365
    [No Abstract]   [Full Text] [Related]  

  • 39. Chromosomal analysis of tumors derived from mouse cells after neoplastic conversion in vitro in various serum-supplemented media.
    Parshad R; Anford KK
    J Natl Cancer Inst; 1969 Jul; 43(1):71-6. PubMed ID: 5796396
    [No Abstract]   [Full Text] [Related]  

  • 40. Viral oncogenicity and virus vaccines--summary.
    Habel K; Murphy WH
    Natl Cancer Inst Monogr; 1968 Dec; 29():561-3. PubMed ID: 5713331
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.